|
TTLL11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.509200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.937900E-03 |
| Normal-vs-Stage2 |
3.611000E-01 |
| Normal-vs-Stage3 |
2.441800E-02 |
| Normal-vs-Stage4 |
2.378400E-03 |
| Stage1-vs-Stage2 |
4.475600E-03 |
| Stage1-vs-Stage3 |
5.01110000050708E-07 |
| Stage1-vs-Stage4 |
6.58490000304823E-08 |
| Stage2-vs-Stage3 |
4.302400E-01 |
| Stage2-vs-Stage4 |
1.249750E-01 |
| Stage3-vs-Stage4 |
3.521200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.469800E-01 |
| Normal-vs-AfricanAmerican |
8.410400E-01 |
| Normal-vs-Asian |
1.938000E-01 |
| Caucasian-vs-AfricanAmerican |
8.549000E-01 |
| Caucasian-vs-Asian |
3.978200E-02 |
| AfricanAmerican-vs-Asian |
7.043900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.182600E-01 |
| Normal-vs-Female |
4.228200E-02 |
| Male-vs-Female |
4.207700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.440800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.366400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.625200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.337600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.262000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.595600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.099400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.534100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.044400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.068400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.79658999999166E-05 |
| Normal-vs-Grade 2 |
9.417000E-03 |
| Normal-vs-Grade 3 |
2.274600E-01 |
| Normal-vs-Grade 4 |
2.42199999999082E-05 |
| Grade 1-vs-Grade 2 |
4.742300E-03 |
| Grade 1-vs-Grade 3 |
3.62780000000562E-05 |
| Grade 1-vs-Grade 4 |
7.55260000095959E-08 |
| Grade 2-vs-Grade 3 |
1.156890E-04 |
| Grade 2-vs-Grade 4 |
2.66260014036845E-10 |
| Grade 3-vs-Grade 4 |
2.062000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.54609999999789E-05 |
| Normal-vs-ccB subtype |
1.120410E-02 |
| ccA subtype-vs-ccB subtype |
3.72160080530648E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.285600E-01 |
| Normal-vs-N1 |
9.486100E-02 |
| N0-vs-N1 |
5.977800E-02 |
|
|
